Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Doses below 0.1mL (10 units) become harder to measure accurately consider reconstituting with more solvent to increase injection volume if your protocol requires very low doses
Minor side effects can include: A bit of tenderness, puffiness, or pink discoloration right around the puncture A brief warm or flushed sensation Mild headache or nausea Reach out to a medical professional right away if you notice: Redness that keeps spreading, heat, or discharge near the site (possible infection) Hives, facial swelling, or difficulty breathing (possible allergic reaction) Persistent numbness or tingling that spreads beyond the site Fever or chills within 48 hours of injection Safe Needle Disposal and Storage A proper FDA-cleared sharps bin is ideal
B12 absorption declines with age (4)
After 16 weeks, patients on Rozebalamin had experienced a 43% lower decline in ALSFRS-R scores, indicating a significant slowing in disease progression, compared with a placebo
So, which one should you choose, B12 oral supplements vs